Cargando...
Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction
The AKR1B10 (aldo-keto reductase family 1 member B10) gene has important functions in carcinogen-induced neoplasia. AKR1B10 is also expressed in type 2 reaction leprosy patients (R2). We measured the expression of AKR1B10 in the skin lesions of patients with leprosy by immunohistochemistry from biop...
Guardado en:
| Publicado en: | Front Med (Lausanne) |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6166685/ https://ncbi.nlm.nih.gov/pubmed/30320113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2018.00263 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|